Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.068 | 0.7 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.072 | 0.7 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.059 | 0.7 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |